Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1122897]Brief description Chikungunya virus (CHIKV) is a globally widespread mosquito-borne alphavirus capable of causing considerable human morbidity and mortality. With no CHIKV vaccine or antiviral available this proposal aims to develop a live attenuated CHIKV vaccine, rationally designed by investigating the host cell nucleolar trafficking of CHIKV capsid protein. This vaccine has the potential to provide cross-protection against additional arthritogenic alphaviruses endemic to Australia such as Ross River virus.
Funding Amount $AUD 533,568.43
Funding Scheme Project Grants
Notes New Investigator Grant
- nhmrc : 1122897
- PURL : https://purl.org/au-research/grants/nhmrc/1122897
